Literature DB >> 30444204

Diabetes Association with Liver Diseases: An Overview for Clinicians.

Abd Elkhalek Hamed1, Nadia Elwan2, Mervat Naguib3, Reda Elwakil4, Gamal Esmat3, Mohamed El Kassas5, Sherief Abd-Elsalam2, Shorouk Moussa3.   

Abstract

BACKGROUND: There is a strong association between liver diseases and diabetes (DM) which is higher than expected by a correlation between two very common diseases. Liver diseases may occur as a result of diabetes, and the reverse is true as well. AIM: To review the etiology of this association between liver diseases and diabetes and how to diagnose it.
METHODS: Studies that identified this association between liver diseases and diabetes and how to diagnose it was reviewed.
RESULTS: This association can be divided into the following categories: liver disease related to diabetes (Diabetic hepatopathy), hepatogenous diabetes (HD), and liver diseases that occur in conjunction with Diabetes mellitus. Two hours after glucose loading is the best screening test for HD. HbA1c may neither be suitable for diagnosis nor monitoring of diabetes that links liver disease.
CONCLUSION: NAFLD, hepatogenous diabetes, glycogenic hepatopathy and diabetic hepatosclerosis are the most important association between liver diseases and diabetes. The criteria for the diagnosis of diabetes associating liver disease are the same for primary diabetes. Two hours post glucose load is the best screening test for HD due to the fact that fasting glucose can be normal early in the disease. The tool used for diabetes monitoring depends on stage and severity of liver condition. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Liver; NAFLD; diabetes mellitus; diabetic hepatopathy; glycogenic hepatopathy; hepatogenous diabetes.

Mesh:

Substances:

Year:  2019        PMID: 30444204     DOI: 10.2174/1871530318666181116111945

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  7 in total

1.  Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus.

Authors:  Kalliopi Azariadis; Nikolaos K Gatselis; George K Koukoulis; Georgios N Dalekos
Journal:  BMJ Case Rep       Date:  2019-03-20

2.  Factors Influencing Selenium Concentration in Community-Dwelling Patients with Type 2 Diabetes Mellitus.

Authors:  Jing Xi; Qianqian Zhang; Jian Wang; Renmei Guo; Li Wang
Journal:  Biol Trace Elem Res       Date:  2020-07-16       Impact factor: 3.738

3.  The Underlying Mechanisms of Curcumin Inhibition of Hyperglycemia and Hyperlipidemia in Rats Fed a High-Fat Diet Combined With STZ Treatment.

Authors:  Zhen-Hong Xia; Wen-Bo Chen; Li Shi; Xue Jiang; Ke Li; Yu-Xiang Wang; Yan-Qiang Liu
Journal:  Molecules       Date:  2020-01-09       Impact factor: 4.411

4.  A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China.

Authors:  Mingyue Xue; Xiaoping Yang; Yuan Zou; Tao Liu; Yinxia Su; Cheng Li; Hua Yao; Shuxia Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-02       Impact factor: 3.168

5.  Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV-VII.

Authors:  Seogoo Han; Gi-Ho Sung; Sangheun Lee; Ki Jun Han; Hyun-Jeong Han
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

6.  A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study.

Authors:  Min Wang; Minxian Wang; Ru Zhang; Liuxin Zhang; Yajie Ding; Zongzhe Tang; Haozhi Fan; Hongliang Wang; Wei Zhang; Yue Chen; Jie Wang
Journal:  PeerJ       Date:  2022-03-04       Impact factor: 2.984

7.  High Albumin Level Is Associated With Regression of Glucose Metabolism Disorders Upon Resolution of Acute Liver Inflammation in Hepatitis B-Related Cirrhosis.

Authors:  Caiyun Tian; Yanping Zhu; Yujuan Liu; Han Hu; Qijiao Cheng; Fangwan Yang; Lingqi Pei; Yihong Zhou; Ying Li; Shide Lin
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.